Systemic Amyloidosis: Is It ATTR or AL? - 20/06/23
Doi : 10.1016/j.amjmed.2023.03.009
Joel Singh, MD a, Jennifer Oliver-Krasinski, MD b, James Tauras, MD c, Benjamin T. Galen, MD d, ⁎ 
a Department of Internal Medicine, Residency Training Program
b Department of Pathology
c Department of Internal Medicine, Division of Cardiovascular Medicine
d Department of Internal Medicine, Division of Hospital Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
⁎Requests for reprints should be addressed to Benjamin T. Galen, MD, Weiler Division, Department of Medicine, Montefiore Medical Center, Suite 2-76, 1825 Eastchester Road, Bronx, NY 10461.Weiler Division, Department of MedicineMontefiore Medical CenterSuite 2-76, 1825 Eastchester RoadBronxNY10461
Thomas J. Marrie, MD, Section Editor
El texto completo de este artículo está disponible en PDF.Esquema
| Funding: The authors have no financial disclosures to report. |
|
| Conflicts of Interest: The authors have no conflicts of interest to disclose. |
|
| Authorship: All authors contributed to the preparation of this manuscript. The patient provided written consent for presentation of his case. |
© 2023
Elsevier Inc. Reservados todos los derechos.
Vol 136 - N° 7
P. 652-654 - juillet 2023 Regresar al número
Artículo precedente
- Lumbar Disc Herniation: Diagnosis and Management
- Andrew S. Zhang, Andrew Xu, Kashif Ansari, Kyle Hardacker, George Anderson, Daniel Alsoof, Alan H. Daniels
- Extensive Palpable Purpura Preceding Renal Dysfunction in Immunoglobulin A Vasculitis Due to Coronavirus-19 Infection
- Carolyn G. Ahlers, Bangchen Wang, David N. Howell, Vinay Choksi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?